Anti-phospholipid syndrome: Current opinion on mechanisms involved, laboratory characterization and diagnostic aspects.

Amiral, Jean; Peyrafitte, Marie; Dunois, Claire; Vissac, Anne Marie; Seghatchian, Jerard

Amiral, Jean; Peyrafitte, Marie; Dunois, Claire; Vissac, Anne Marie; Seghatchian, Jerard.

Afiliação

Amiral J; SH-Consulting, Andrésy, France; Scientific and Technical Advisor for Hyphen BioMed, Sysmex Group, Neuville-sur-Oise, France. Electronic address: jamiral@hyphen-biomed.com.
Peyrafitte M; Validation Manager, HYPHEN BioMed, Neuville-sur-Oise, France.
Dunois C; Clinical Studies Director, HYPHEN BioMed, Neuville-sur-Oise, France.
Vissac AM; Technical Director, HYPHEN BioMed, Neuville-sur-Oise, France.
Seghatchian J; International Consultancy in Blood Components Quality/Safety Improvement, Audit/Inspection and DDR Strategies, London, UK. Electronic address: jseghatchian@btopenworld.com.

Transfus Apher Sci ; 56(4): 612-625, 2017 Aug.

Article em En | MEDLINE | ID: mdl-28803708

Assuntos

Síndrome Antifosfolipídica/sangue; Síndrome Antifosfolipídica/diagnóstico; Anexina A5/metabolismo; Anticorpos Anticardiolipina/sangue; Síndrome Antifosfolipídica/terapia; Proteínas Sanguíneas/metabolismo; Fator XIII/metabolismo; Humanos; Inibidor de Coagulação do Lúpus/sangue; Tempo de Tromboplastina Parcial/métodos; Proteína S/metabolismo; Protrombina/metabolismo; Tempo de Protrombina/métodos

Palavras-chave

Anti-phospholipid syndrome; Phospholipid dependent antibodies; Prothrombin; Thrombosis; ß2-Glycoprotein 1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome Antifosfolipídica Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google